Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07678060 · ClinicalTrials.gov registry record · NA
Targeting Fronto-Striatal Neural Circuitry Using Repetitive Transcranial Magnetic Stimulation to Reduce Irritability
A NA study, sponsored by Yale University.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07678060: Active NA study, sponsored by Yale University.
NCT07678060 is a NA study that is active but no longer recruiting, run by Yale University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07678060, a NA study, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This pilor study will use repetitive Transcranial Magnetic Stimulation (rTMS) as a noninvasive circuit-based neural modulation to test frontostriatal circuitry as a potential target to reduce irritability.
Primary Outcome
Frontostriatal connectivity easured using fMRI during a frustration task. The unit of measure is degrees of functional connectivity.
Interventions
- DEVICE repetitive transcranial magnetic stimulation (rTMS)
- DIAGNOSTIC_TEST fMRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2026-08 |
| Phase | NA |
What the registry record for NCT07678060 still lists
NCT07678060 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT07678060 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07678060 about?
NCT07678060 is a clinical study titled "Targeting Fronto-Striatal Neural Circuitry Using Repetitive Transcranial Magnetic Stimulation to Reduce Irritability". This pilor study will use repetitive Transcranial Magnetic Stimulation (rTMS) as a noninvasive circuit-based neural modulation to test frontostriatal circuitry as a potential target to reduce irritability.
What is the current status of trial NCT07678060?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-09-01. Estimated completion is 2026-08.
What interventions are being tested in trial NCT07678060?
The interventions under investigation include: repetitive transcranial magnetic stimulation (rTMS) (DEVICE), fMRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07678060?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07678060's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI